Dan Crowley | Chief Executive Officer
RemedyBio
Dan Crowley is co-founder and CEO of RemedyBio, a single cell technology company focused on patient-derived discovery in cancer and autoimmune disease. Prior to RemedyBio, Dan co-founded and led Genomics Medicine Ireland (acquired in 2018) and was a Venture Partner with Arch Venture Partners. He serves on the board of the AMBER Centre for Advanced Materials and Bioengineering Research headquartered at Trinity College Dublin. Dan holds a BA and MSc from Trinity College Dublin, a PDip from Oxford University, received his MBA from Cornell where he was an Angear Merit Scholar, and is a Kauffman Fellow.
Appearances:
BioTechX Europe Day 1 @ 17:25
Panel discussion: Interface of Immune Diversity & Data Sets
Get involved at BioTechX
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events